Amyris Is Selected by NIH Grant Recipient, IDRI, to Engineer Molecules for Vaccine Adjuvant Applications  GlobeNewswireSustainable Squalene Replacement Needed for Pharma. EMERYVILLE, Calif. and SEATTLE, Feb. 12, 2019 (GLOBE NEWSWIRE) -- Amyris, I …